Sign Up Today and Learn More About Elysium Health Stock
Invest in or calculate the value of your shares in Elysium Health or other pre-IPO companies through EquityZen's platform.
About Elysium Health Stock
Founded
2014
Headquarters
New York, NY, US
Total Funding
29.3M
Industries
Science and Engineering, Health Care, Biotechnology
Elysium Health’s mission is to solve the challenges in health with science, to help people live healthier and longer. Elysium works directly with scientists, clinicians and health professionals worldwide the world to translate advances in science and technology into innovative health products that work. Our product development pipeline begins with research and development, continues with preclinical studies, and culminates with human clinical trials to demonstrate the safety and efficacy of products. Throughout this process, Elysium’s focus is to develop compounds found in nature that allow people to support their health proactively. Elysium is guided by a Scientific Advisory Board, which includes multiple winners of the Nobel Prize, as well as researchers and doctors who are experts in chemistry, physiology, neuroscience, complex chemical systems, biochemistry, and many other fields of study. Basis, Elysium Health’s first product, is a proprietary formulation of two ingredients designed to support long-term health at the cellular level. Basis is clinically proven to increase NAD+ levels, which decline with age. NAD+ is required for energy creation, regulating circadian rhythms, maintaining healthy DNA, and hundreds of other biological functions. Learn more via our science journal Endpoints: https://endpoints.elysiumhealth.com
Elysium Health Press Mentions
Stay in the know about the latest news on Elysium Health
Elysium Health unveils vision for eye health and longevity
longevity • Oct 18, 2024
Elysium Investments Surpasses $200M in Acquisitions, Closing in on 4,000 Units and $3B Under Development
newswire • Sep 26, 2024
Financial boost for Elysium’s bitcoin solutions
startupticker • Jun 10, 2024
Elysium unveils the “Elysium Accelerator Program”: Empowering Web3 game development
cointelegraph • Feb 16, 2024
Nomura’s digital asset biz Laser acquires post trade firm Elysium
ledgerinsights • Jul 01, 2023
Investors in Elysium Health
Discover investors in Elysium Health stock and explore their portfolio companies
Elysium Health Management
Leadership team at Elysium Health
CEO & Co-Founder
Eric Marcotulli
COO & Co-Founder
Dan Alminana
Join now and verify your accreditation status to gain access to:
- Elysium Health current valuation
- Elysium Health stock price
- Available deals in Elysium Health and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Elysium Health stock?
Accredited investors can buy pre-IPO stock in companies like Elysium Health through EquityZen funds. These investments are made available by existing Elysium Health shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Elysium Health stock?
Shareholders can sell their Elysium Health stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
